Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study.

Nelson TL, Biggs ML, Kizer JR, Cushman M, Hokanson JE, Furberg CD, Mukamal KJ.

J Clin Endocrinol Metab. 2012 May;97(5):1695-701. doi: 10.1210/jc.2011-3026. Epub 2012 Mar 7.

2.

Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study.

Nelson TL, Kamineni A, Psaty B, Cushman M, Jenny NS, Hokanson J, Furberg C, Mukamal KJ.

Diabetologia. 2011 Feb;54(2):329-33. doi: 10.1007/s00125-010-1969-4. Epub 2010 Nov 20.

3.

Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk.

Onat A, Hergenç G, Can G, Uğur M, Nartop F.

Clin Chem Lab Med. 2011 Aug;49(8):1349-57. doi: 10.1515/CCLM.2011.110. Epub 2011 Jul 14.

PMID:
21756164
4.

Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.

Garg PK, McClelland RL, Jenny NS, Criqui MH, Greenland P, Rosenson RS, Siscovick DS, Jorgensen N, Cushman M.

Atherosclerosis. 2015 Jul;241(1):176-82. doi: 10.1016/j.atherosclerosis.2015.05.006. Epub 2015 May 16.

5.

Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health Study.

Jenny NS, Solomon C, Cushman M, Tracy RP, Nelson JJ, Psaty BM, Furberg CD.

Atherosclerosis. 2010 Apr;209(2):528-32. doi: 10.1016/j.atherosclerosis.2009.09.021. Epub 2009 Sep 20.

6.

Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study.

Suzuki T, Solomon C, Jenny NS, Tracy R, Nelson JJ, Psaty BM, Furberg C, Cushman M.

Circ Heart Fail. 2009 Sep;2(5):429-36. doi: 10.1161/CIRCHEARTFAILURE.108.839613. Epub 2009 Jun 19.

7.

Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study.

Garg PK, Arnold AM, Hinckley Stukovsky KD, Koro C, Jenny NS, Mukamal KJ, Criqui MH, Furberg CD, Newman AB, Cushman M.

Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):750-6. doi: 10.1161/ATVBAHA.115.306647. Epub 2016 Feb 4.

8.

Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.

Persson M, Hedblad B, Nelson JJ, Berglund G.

Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1411-6. Epub 2007 Apr 12.

9.

Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study.

Furberg CD, Nelson JJ, Solomon C, Cushman M, Jenny NS, Psaty BM.

J Am Geriatr Soc. 2008 May;56(5):792-9. doi: 10.1111/j.1532-5415.2008.01667.x. Epub 2008 Mar 21.

PMID:
18363676
10.
11.

Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study.

Tsimikas S, Willeit J, Knoflach M, Mayr M, Egger G, Notdurfter M, Witztum JL, Wiedermann CJ, Xu Q, Kiechl S.

Eur Heart J. 2009 Jan;30(1):107-15. doi: 10.1093/eurheartj/ehn502. Epub 2008 Nov 19.

PMID:
19019993
12.

Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study.

Fitzpatrick AL, Irizarry MC, Cushman M, Jenny NS, Chi GC, Koro C.

Atherosclerosis. 2014 Aug;235(2):384-91. doi: 10.1016/j.atherosclerosis.2014.04.032. Epub 2014 May 22.

13.

Carotid intima media thickness is associated with plasma lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in patients with type 2 diabetes.

Constantinides A, van Pelt LJ, van Leeuwen JJ, de Vries R, Tio RA, van der Horst IC, Sluiter WJ, Dullaart RP.

Eur J Clin Invest. 2011 Aug;41(8):820-7. doi: 10.1111/j.1365-2362.2011.02471.x. Epub 2011 Jan 31.

PMID:
21281278
14.

Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: the ATTICA Study.

Tselepis AD, Panagiotakos DB, Pitsavos C, Tellis CC, Chrysohoou C, Stefanadis C.

Atherosclerosis. 2009 Sep;206(1):303-8. doi: 10.1016/j.atherosclerosis.2009.02.016. Epub 2009 Feb 21.

PMID:
19394616
15.

Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.

Kiechl S, Willeit J, Mayr M, Viehweider B, Oberhollenzer M, Kronenberg F, Wiedermann CJ, Oberthaler S, Xu Q, Witztum JL, Tsimikas S.

Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1788-95. Epub 2007 May 31.

18.

Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.

Robins SJ, Collins D, Nelson JJ, Bloomfield HE, Asztalos BF.

Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1172-8. doi: 10.1161/ATVBAHA.107.160739. Epub 2008 Mar 20.

19.

Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study.

Daniels LB, Laughlin GA, Sarno MJ, Bettencourt R, Wolfert RL, Barrett-Connor E.

J Am Coll Cardiol. 2008 Mar 4;51(9):913-9. doi: 10.1016/j.jacc.2007.10.048.

20.

Lipoprotein-associated phospholipase A2, hormone use, and the risk of ischemic stroke in postmenopausal women.

Wassertheil-Smoller S, Kooperberg C, McGinn AP, Kaplan RC, Hsia J, Hendrix SL, Manson JE, Berger JS, Kuller LH, Allison MA, Baird AE.

Hypertension. 2008 Apr;51(4):1115-22. doi: 10.1161/HYPERTENSIONAHA.107.103721. Epub 2008 Feb 7.

Supplemental Content

Support Center